HPLC-DAD and HPLC-MS findings in a fatality involving (Z)-cis- clopenthixol (zuclopenthixol)

Journal of Analytical Toxicology

Volumn 21, Issue 4, 1997, Pages 314-318

  Tracqui, A ^a   Kintz, P ^a   Cirimele, V ^a   Berthault, F ^a   Mangin, P ^a   Ludes, B ^a  

^a INSTITUT DE MÉDECINE LÉGALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; THIOXANTHENE DERIVATIVE; ZUCLOPENTHIXOL;

ARTICLE; CASE REPORT; DRUG DETERMINATION; DRUG FATALITY; DRUG OVERDOSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; SUICIDE;

EID: 0030876591     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/21.4.314     Document Type: Article

References (19)

1. Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Post-Mortem Material. 2nd ed. A.C. Moffat, Ed. The Pharmaceutical Press, London, U.K., 1986. pp 483-64.
2. The Merck Index. 11 th ed. S. Budavari, Ed. Merck & Co., Rahway, NJ, 1989. pp 374-75.
3. A. Gravem and A. Bugge. cis (Z)-Clopenthixol. The neuroleptically active isomer of clopenthixol. A presentation of five double-blind clinical investigations and other studies with cis (Z)-clopenthixol (Cisordinol, Clopixol). Acta Psychiatr. Scand. 64(suppl. 294): 5-12(1981).
4. Martindale - The Extra Pharmacopoeia. 29th ed. J.E.F. Reynolds, Ed. The Pharmaceutical Press, London, U.K., 1989. pp 775-76.
5. J.A. Kurtzhals, B.J. Andersen, J.E. Kristiansen, and S. Jepsen. Effect of trans (E)-clopenthixol on Plasmodium berghei in vivo. APMIS 96: 357-60 (1988).
6. A. Li Wan Po and W.J. Irwin. The photochemical stability of cis-and trans-isomers of tricyclic neuroleptic drugs. J. Pharm. Pharmacol. 32: 25-29 (1980).
7. B.B. Hansen and S.H. Hansen. Determination of zuclopenthixol and its main N-dealkylated metabolite in biological fluids using high-performance liquid chromatography with post-column photochemical derivatization and fluorescence detection. J. Chromatogr. B. 658: 319-25 (1994).
8. T. Aaes-Jørgensen. Specific HPLC method for estimation of the cis (Z)-and trans (E)-isomers of clopenthixol and a N-dealkyl-metabolite. J. Chromatogr. 183: 239-45 (1980).
9. T. Solgaard, K. Kistrup, T. Aaes-Jørgensen, and J. Gerlach. Zuclopenthixol decanoate in maintenance treatment of schizophrenia outpatients. Minimum effective dose and corresponding serum levels. Pharmacopsychiatry 27: 119-23 (1994).
10. T. Aaes-Jørgensen. Pharmacokinetics of three different injectable zuclopenthixol preparations. Prog. Neuropsychopharmacol. Biol. Psychiatry 13: 77-85 (1989).
11. A. Tracqui, P. Kintz, and P. Mangin. Systematic toxicological analysis using HPLC/DAD. J. Forensic Sci. 40:112-20 (1995).
12. T. Aaes-Jørgensen. Serum concentrations of cis (Z)-and trans (E)-clopenthixol after administration of cis (Z)-clopenthixol and clopenthixol to human volunteers. Acta Psychiatr. Scand. 64(suppl. 294): 64-69 (1981).
13. S.J. Dencker, U. Malm, A. Jørgensen, and K.F. Overø. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome. Acta Psychiatr. Scand. 61 (suppl. 279): 55-63 (1980).
14. A. Viala, B. Ba, A. Durand, F. Gouezo, N. Hou, and J. Jørgensen. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate. Psychopharmacology 94: 293-97 (1988).
15. A.C. Tas, J. Van der Greef, M.C. ten Noever de Brauw, T.A. Plomp, R.A.A. Maes, M. Hohn, and U. Rapp. LC/MS determination of bromazepam, clopenthixol, and reserpine in serum of a non-fatal case of intoxication. J. Anal. Toxicol. 10: 46-48 (1986).
16. A. Tracqui, P. Kintz, P. Kreissig, and P. Mangin. Simple and rapid screening procedure for 27 neuroleptics using HPLC/DAD. J. Liq. Chromatogr. 15:1381-96 (1992).
17. A. Tracqui, P. Kintz, P. Kreissig, and P. Mangin. A simple and rapid method for toxicological screening of 25 antidepressants in blood or urine using high-performance liquid chromatography with diode-array detection. Ann. Biol. Clin. 50: 639-47 (1992).
18. M. Schorderet and A. Calanca. Neuroleptiques (antipsychotiques). In Pharmacologie - Des Concepts Fondamentaux aux Applications Thérapeutiques. M. Schorderet, Ed. Frisons-Roche/Slatkine, Paris, France, 1989. pp 364-84.
19. M. Kjolbye, K. Thomsen, T. Rogne, E. Rehfelt, and O.V. Olesen. Search for a therapeutic range for serum zuclopenthixol concentrations in schizophrenic patients. Ther. Drug Monit. 16:541-47 (1994).